ASBP
Aspire Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.87
−4.11%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.03x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- -3.70x
Liquidity & coverage
- Current ratio
- 7.99x
- Quick ratio
- 7.81x
- Cash ratio
- 7.22x
- Interest coverage
- -0.76x
- EBITDA / interest
- 0.35x
- Working capital
- $11.8M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026